Zinc oxide vs MEBO for stage 2 pressure ulcers
Official title: Impact of Using Zinc Oxide Versus Moist Exposed Wound Ointment (MEBO) in Treatment of Second Stage Pressure Ulcer: A Randomized Control Clinical Trial
Run by King Abdullah Medical City · NCT07193849 · Data updated 2026-11-12
This trial tests whether applying zinc oxide or MEBO ointment heals stage 2 pressure ulcers faster in hospitalized patients.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 76 (estimated) |
| Sponsor | King Abdullah Medical City Government |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 2 sites (Mecca, Western Reagan and 1 other locations) |
| Status | Recruiting |
| Started | December 31, 2023 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2025 |
| Registry record updated | September 26, 2025 |
| Trial ID | NCT07193849 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Hospitalized patients at King Abdullah Medical City with newly diagnosed stage 2 pressure ulcers who consent and are not receiving therapies that interfere with wound healing are eligible.
✕Probably not a fit
Patients with stage III/IV ulcers, deep tissue injury, signs of wound infection, hypersensitivity to the ointments, active cancer therapies, or heavy smoking are excluded and unlikely to benefit from these interventions.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults with newly diagnosed stage 2 pressure ulcers at King Abdullah Medical City are randomized 1:1 to receive either topical zinc oxide or MEBO ointment. Treatments are applied twice every 12 hours and patients are examined daily until complete healing or for up to one month. Wound healing is measured using the Bates-Jensen Wound Assessment Tool and data are recorded on a standardized assessment sheet. Randomization is performed electronically in R using the Random Allocation Rule.
Why it matters
Potential benefit: If successful, one ointment could speed healing of stage 2 pressure ulcers and reduce complications and length of stay.
How similar studies have gone: Topical zinc formulations and moist-exposed ointments have shown wound-healing benefits in other settings, but direct head-to-head comparisons for stage 2 pressure ulcers are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Willing to participate. * KAMC cases in medical ward, neuroscience ward, and intensive care unit. * Newly cases diagnosed with second stage pressure ulcer according to the European pressure ulcer advisory panel/national pressure ulcer advisory panel (NPUAP) guidelines. Exclusion Criteria: * Not consenting to participate * Patients with suspected hypersensitivity reactions to any of the topical formulation's ingredients. * Either a category III or IV pressure ulcer. * Evidence of deep tissue injury (exudative drainage, purple or maroon localized area of discolored intact skin or blood-filled blister due to pressure damage). * Signs of wound infection (pus draining from the ulcer, a foul-smelling odour, tenderness, heat and increased redness in the surrounding skin and fever). * Patients who undertaking other therapies that could affect healing, such as corticosteroids, radiation therapy, or chemotherapy for cancer. * Heavy smoking (more than 20 cigarettes a day). * Concomitant chronic disease (e.g., diabetes mellitus or frank vascular disease such as Buerger's disease). * Patients who unable to continue the study because of death, discharge, or change in the care setting.
Where it's running
-
King Abdulla Medical City in Holy capital
Mecca, Western Reagan, Saudi Arabia Recruiting -
King Abdulla Medical City in Holy capital
Mecca, Western Reagan, Saudi Arabia Completed
Study contacts
- Principal investigator: Dr. Ebtisam AbdElatif Ebrahim, Master degree of science in nu — King Abdullah Medical City in Holy Capital
- Study coordinator: wedian Almowallad, Master
- Email: Almwlld.W@kamc.med.sa
- Phone: +96612 5549999
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Artificial Intelligence-Supported Pressure Injury Prevention in ICU Patients
This study tests PRESS AI, a mobile app, to help nurses prevent and manage pressure injuries in adult ICU patients by guiding risk and wound assessment and care decisions.
-
Tocotrienol-loaded Dressing for Stage 1–2 Pressure Ulcers
Atocotrienol-containing wound dressing is being tested to see if it helps heal stage 1–2 pressure ulcers better than standard dressings.
-
Paraffin oil to protect skin from tourniquet damage during upper limb surgery
This trial will try applying topical paraffin oil to the skin of adults having elective upper extremity surgery to see if it prevents tourniquet-related redness, blisters, or abrasions.
-
NeoThelium FT treatment for chronic pressure ulcers
This project will try NeoThelium FT amnion skin graft plus usual wound care in adults with stage 2–3 chronic pressure ulcers to see if it helps wounds heal and is safe.
-
Cellular, acellular, and matrix wound products plus standard care for nonhealing stage 3–4 pressure ulcers
This study will try several cellular, acellular, and matrix-like wound products with standard care to see if adults with nonhealing stage 3–4 pressure ulcers heal more completely over 20 weeks than with standard care alone.
-
Standardized laryngeal mask airway placement with cuff pressure monitoring for older adults
This tests whether using a cuff pressure monitor when placing a laryngeal mask airway reduces airway-related adverse reactions in older adults having elective surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.